European Health Summit Rare Disease Edition in Madrid
The European Health Summit will bring the rare diseases community together in Madrid on 10 November 2026 to connect national priorities with Europe…
Dissemination
The latest news, publications and events from the ERAMET consortium.
The European Health Summit will bring the rare diseases community together in Madrid on 10 November 2026 to connect national priorities with Europe…
The study of monoclonal antibodies for moderate-to-severe asthma examines how modelling and simulation have supported their development and regula…
A review of six authorised CAR-T therapies examines how modelling and simulation have supported their development and regulatory approval in Europe…
An ERAMET-supported review examines how modelling and simulation are used in medicine development for sickle cell disease and thalassaemia. Drawing…
A five-year review of EMA Scientific Advice explores how concentration-QT modelling can support cardiac safety assessments and requests to waive de…
A recent study comparing SIMCYP and PK-Sim shows how differences between modelling platforms can lead to clinically relevant variations in predicte…
A new study explores how modelling and simulation can support the development of antibiotics for children using ceftriaxone as a case study to hig…
ERAMET will contribute to the TEDDY General Assembly and Scientific Meeting 2026 through a dedicated panel on how innovative methodologies can stre…
A new publication in Clinical Pharmacology & Therapeutics highlights how innovative model-informed approaches can support more efficient evidence g…
The University of Catania is pleased to announce the opening of applications for its new International PhD Programme in Pharmaceutical Sciences, a …
Francesco Pappalardo, from the University of Catania, presented ERAMET as a concrete example of an ecosystem supporting pediatric rare disease rese…